PMS 9 · Cell cycle, oncogenes and tumor suppressors
Friday .::. 28 September .::. 14:00-16:00
PMS.9 · 0+P4 
CDK4 is a direct MYCN target in neuroblastoma
C. Rizzato1, J. Batzler2, D. Muth2, A. Benner3, M. Fischer4, B. Brors3, M. Schwab2, F. Westermann2
1Dept Biology, Univ. Pisa; Division of Tumor Genetics, German Cancer Research Center (DKFZ) (Heidelberg, Germany); 2Dept of Tumor Genetics, German Cancer Research Center (DKFZ) (Heidelberg, Germany); 3Dept of Theoretical Bioinformatics, German Cancer Research Center (DKFZ) (Heidelberg, Germany); 4Children's Hospital, Dept of Pediatric Oncology and Hematology and Center for Molecular Medicine Cologne (CMMC), Univ. of Cologne (Cologne, Germany)

CDK4 is a direct MYCN target in neuroblastoma
C. Rizzato1, J. Batzler2, D. Muth2, A. Benner3, M. Fischer4, B. Brors3, M. Schwab2, F. Westermann2
1Dept Biology, Univ. Pisa; Division of Tumor Genetics, German Cancer Research Center (DKFZ) (Heidelberg, Germany); 2Dept of Tumor Genetics, German Cancer Research Center (DKFZ) (Heidelberg, Germany); 3Dept of Theoretical Bioinformatics, German Cancer Research Center (DKFZ) (Heidelberg, Germany); 4Children's Hospital, Dept of Pediatric Oncology and Hematology and Center for Molecular Medicine Cologne (CMMC), Univ. of Cologne (Cologne, Germany)
PMS.9 · 0+P7 
Eukaryotic initiation Factor 6 is a rate-limiting controller of translation, growth and tumorigenesis
V. Gandin1, A. Miluzio1, A. Barbieri1, L. Magri1, P.C. Marchisio1, H. Kiyokawa2, S. Biffo1,3
1Molecular Histology and Cell Growth Unit, DIBIT-San Raffaele Hospital (Milan); 2Northwestern Univ, Feinberg School of Medicine (Chicago, USA); 3DISAV, Univ. Eastern Piedmont (Alessandria)

Eukaryotic initiation Factor 6 is a rate-limiting controller of translation, growth and tumorigenesis
V. Gandin1, A. Miluzio1, A. Barbieri1, L. Magri1, P.C. Marchisio1, H. Kiyokawa2, S. Biffo1,3
1Molecular Histology and Cell Growth Unit, DIBIT-San Raffaele Hospital (Milan); 2Northwestern Univ, Feinberg School of Medicine (Chicago, USA); 3DISAV, Univ. Eastern Piedmont (Alessandria)
PMS.9 · P9 
RanBP1 regulates mitotic microtubule stability and chromosome segregation
M. Ciciarello1, R. Mangiacasale1, A. Tedeschi1,2, E. Roscioli1, W. Rensen1, P. Lavia1
1Inst. Molecular Biology and Pathology, National Research Council, c/o Univ. Rome "La Sapienza" (Rome); 2Research Institute of Molecular Pathology (IMP) (Vienna, Austria)

RanBP1 regulates mitotic microtubule stability and chromosome segregation
M. Ciciarello1, R. Mangiacasale1, A. Tedeschi1,2, E. Roscioli1, W. Rensen1, P. Lavia1
1Inst. Molecular Biology and Pathology, National Research Council, c/o Univ. Rome "La Sapienza" (Rome); 2Research Institute of Molecular Pathology (IMP) (Vienna, Austria)
PMS.9 · P10 
Delayed entry to quiescence in p21CDKN1A-null human fibroblasts: a possible involvement of DNA damage checkpoint
P. Perucca1, O. Cazzalini1, M. Savio1, T. Coppa1, R.A.L. Laskey3, E. Prosperi2, L.A. Stivala1
1Dept Experimental Medicine, Univ. Pavia (Pavia); 2Institute of Molecular Genetic, CNR (Pavia); 3Hutchison/MRC Research Centre (Cambridge, United Kingdom)

Delayed entry to quiescence in p21CDKN1A-null human fibroblasts: a possible involvement of DNA damage checkpoint
P. Perucca1, O. Cazzalini1, M. Savio1, T. Coppa1, R.A.L. Laskey3, E. Prosperi2, L.A. Stivala1
1Dept Experimental Medicine, Univ. Pavia (Pavia); 2Institute of Molecular Genetic, CNR (Pavia); 3Hutchison/MRC Research Centre (Cambridge, United Kingdom)
PMS.9 · P12 
Interplay between typical and atypical Arabidopsis E2Fs in cell cycle progression and development
C. Maggio1, R. Sozzani1, L. Concia1, P. Longoni1, C. Bergounioux2, R. Giordo3, D. Albani3, R. Cella1
1Dip. di Genetica e Microbiologia (Pavia); 2Inst. of Plant Biotechnology (Orsay, France); 3Dip. di Botanica ed Ecologia Vegetale (Sassari)

Interplay between typical and atypical Arabidopsis E2Fs in cell cycle progression and development
C. Maggio1, R. Sozzani1, L. Concia1, P. Longoni1, C. Bergounioux2, R. Giordo3, D. Albani3, R. Cella1
1Dip. di Genetica e Microbiologia (Pavia); 2Inst. of Plant Biotechnology (Orsay, France); 3Dip. di Botanica ed Ecologia Vegetale (Sassari)
PMS.9 · P13 
Uncapped telomeres activate multiple cell cycle checkpoints in Drosophila
M. Musarò1, L. Ciapponi2, B. Fasulo3, M. Gatti2, G. Cenci1
1DiSTeBA (Lecce); 2Dip. di Genetica e Biologia Molecolare, Univ. di Roma "La Sapienza" (Rome); 3Molecular Cell and Developmental Biology, Univ. of California (Santa Cruz, CA, USA)

Uncapped telomeres activate multiple cell cycle checkpoints in Drosophila
M. Musarò1, L. Ciapponi2, B. Fasulo3, M. Gatti2, G. Cenci1
1DiSTeBA (Lecce); 2Dip. di Genetica e Biologia Molecolare, Univ. di Roma "La Sapienza" (Rome); 3Molecular Cell and Developmental Biology, Univ. of California (Santa Cruz, CA, USA)
PMS.9 · P18 
Thyroid hormone T3 : dual effect on proliferation in human endocrine tumor cells
S. Michienzi1,2, G. Moriggi1,2, C. Verga Falzacappa1,2, V. Patriarca1,2, C. Mangialardo1,2, A. Stigliano1,2, V. Toscano1, S. Misiti1,2
1Chair of Endocrinology, II Faculty of Medicine, Sapienza, Univ. Rome (Rome); 2Centro Ricerca AFaR, Ospedale San Pietro FBF (Rome)

Thyroid hormone T3 : dual effect on proliferation in human endocrine tumor cells
S. Michienzi1,2, G. Moriggi1,2, C. Verga Falzacappa1,2, V. Patriarca1,2, C. Mangialardo1,2, A. Stigliano1,2, V. Toscano1, S. Misiti1,2
1Chair of Endocrinology, II Faculty of Medicine, Sapienza, Univ. Rome (Rome); 2Centro Ricerca AFaR, Ospedale San Pietro FBF (Rome)
PMS.9 · P21 
AP-2α and AP-2γ regulate chemotherapy-induced apoptosis in epithelial tumors
E. Penna1, F. Orso1, P. Sismondi1, M. de Bortoli1,2, D. Taverna1,2
1Dept Oncological Science, Univ. Torino and Inst. for Cancer Research and Treatment (IRCC) (Torino); 2Centro Interdipartimentale Sistemi Complessi in Biologia e Medicina Molecolare c/o DBAU (Torino)

AP-2α and AP-2γ regulate chemotherapy-induced apoptosis in epithelial tumors
E. Penna1, F. Orso1, P. Sismondi1, M. de Bortoli1,2, D. Taverna1,2
1Dept Oncological Science, Univ. Torino and Inst. for Cancer Research and Treatment (IRCC) (Torino); 2Centro Interdipartimentale Sistemi Complessi in Biologia e Medicina Molecolare c/o DBAU (Torino)
PMS.9 · P23 
AcP1 gene and cancerogenesis.
D. Cirelli1, E. Caproni1, R. Marzocchini1, F. Malentacchi2, G. Pepe3, G. Raugei1
1Dept Biochemical Sciences, Univ. Florence (Florence); 2Dept Clinical Physiopathology, Univ. Florence (Florence); 3Dept Medical and Surgical Critical Care, Univ. Florence (Florence)

AcP1 gene and cancerogenesis.
D. Cirelli1, E. Caproni1, R. Marzocchini1, F. Malentacchi2, G. Pepe3, G. Raugei1
1Dept Biochemical Sciences, Univ. Florence (Florence); 2Dept Clinical Physiopathology, Univ. Florence (Florence); 3Dept Medical and Surgical Critical Care, Univ. Florence (Florence)
PMS.9 · P24 
Inflammation-associated centrosomal lesions in esophageal stem cells and their progenies
D. Segat1, E. Dazzo1, M. Cassaro2, C. Romualdi1, M. Rugge3, E. Ancona3, G. Zaninotto4, M.D. Baroni1
1Dept of Biology, Univ. Padua (Padua); 2Dept of Oncological and Surgical Science, Univ. of Padua (Padua); 3Dept of Endoscopy and Pathology and Dept of Surgery, Istituto Oncologico Veneto I.R.C.S.S. (Padua); 4Dept of General Surgery, S. Giovanni e Paolo Hospital (Venice)

Inflammation-associated centrosomal lesions in esophageal stem cells and their progenies
D. Segat1, E. Dazzo1, M. Cassaro2, C. Romualdi1, M. Rugge3, E. Ancona3, G. Zaninotto4, M.D. Baroni1
1Dept of Biology, Univ. Padua (Padua); 2Dept of Oncological and Surgical Science, Univ. of Padua (Padua); 3Dept of Endoscopy and Pathology and Dept of Surgery, Istituto Oncologico Veneto I.R.C.S.S. (Padua); 4Dept of General Surgery, S. Giovanni e Paolo Hospital (Venice)
PMS.9 · P27 
Antiproliferative and proapoptotic effects of a new combi-molecule on non small cell lung cancer cell lines
R. Alfieri1, A. Cavazzoni1, C. Carmi2, M. Galetti1, V. Zuliani2, C. Fumarola1, M. Mor2, P.G. Petronini1
1Dept Experimental Medicine, Univ. Parma (Parma); 2Pharmaceutical Dept, Univ. Parma (Parma)

Antiproliferative and proapoptotic effects of a new combi-molecule on non small cell lung cancer cell lines
R. Alfieri1, A. Cavazzoni1, C. Carmi2, M. Galetti1, V. Zuliani2, C. Fumarola1, M. Mor2, P.G. Petronini1
1Dept Experimental Medicine, Univ. Parma (Parma); 2Pharmaceutical Dept, Univ. Parma (Parma)
PMS.9 · P29 
Impaired differentiation in plantar keratinocytes from Rspo mutated - XX sex reversal patient
L. Panacchia1, O. Radi2, P. Parma2, S. Bondanza1, R. Maurelli1, E. Dellambra1, G. Camerino2, L. Guerra1
1Laboratory of Tissue Engineering and Cutaneous Physiopathology, IDI-IRCCS, Pomezia (Rome); 2Dip. di Patologia Umana ed Ereditaria, Sezione di Biologia Generale e Genetica Medica, Univ. di Pavia (Pavia)

Impaired differentiation in plantar keratinocytes from Rspo mutated - XX sex reversal patient
L. Panacchia1, O. Radi2, P. Parma2, S. Bondanza1, R. Maurelli1, E. Dellambra1, G. Camerino2, L. Guerra1
1Laboratory of Tissue Engineering and Cutaneous Physiopathology, IDI-IRCCS, Pomezia (Rome); 2Dip. di Patologia Umana ed Ereditaria, Sezione di Biologia Generale e Genetica Medica, Univ. di Pavia (Pavia)
PMS.9 · P32 
Knock down of ATM and ATR induces p53 displacement from centrosomes in human primary cells
R. Burla1, P. Caruso1, S. Piersanti1,2, C. Remoli1,2, E. Cundari1,3, I. Saggio1,2,3
1Dept of Genetics and Molecular Biology, Univ. of Rome "La Sapienza” (Rome); 2Fondazione Parco San Raffaele (Rome); 3IBPM CNR (Rome)

Knock down of ATM and ATR induces p53 displacement from centrosomes in human primary cells
R. Burla1, P. Caruso1, S. Piersanti1,2, C. Remoli1,2, E. Cundari1,3, I. Saggio1,2,3
1Dept of Genetics and Molecular Biology, Univ. of Rome "La Sapienza” (Rome); 2Fondazione Parco San Raffaele (Rome); 3IBPM CNR (Rome)
PMS.9 · P33 
Biochemical and immunohistochemical characterization of human RNASET2 expression
P. Campomenosi1, S. Salis1, C. Riva2, S. Marchet2, L. Giuliani1, C. Lindqvist3, F. Acquati1, L. Monti1, C. Capella2, R. Taramelli1
1Dept Biotechnologies and Molecular Sciences, Univ. Insubria (Varese); 2Dept of AnathomoPathology, Univ. of Insubria (Varese); 3Dept of Biochemistry and Pharmacy, Abo Akademi Univ. (Turku, Finland)

Biochemical and immunohistochemical characterization of human RNASET2 expression
P. Campomenosi1, S. Salis1, C. Riva2, S. Marchet2, L. Giuliani1, C. Lindqvist3, F. Acquati1, L. Monti1, C. Capella2, R. Taramelli1
1Dept Biotechnologies and Molecular Sciences, Univ. Insubria (Varese); 2Dept of AnathomoPathology, Univ. of Insubria (Varese); 3Dept of Biochemistry and Pharmacy, Abo Akademi Univ. (Turku, Finland)
PMS.9 · P34 
HIPK2 contributes to the divergent cell responses elicited by the specific p53 inducers RITA and Nutlin-3
C. Rinaldo1, A. Prodosmo1, F. Siepi1, A. Sacchi1, G. Selivanova2, S. Soddu1
1Dept Experimental Oncology, Regina Elena Cancer Inst. (Rome); 2Dept Microbiology, Tumor and Cell Biology, Karolinska Inst (Stockholm, Sweden)

HIPK2 contributes to the divergent cell responses elicited by the specific p53 inducers RITA and Nutlin-3
C. Rinaldo1, A. Prodosmo1, F. Siepi1, A. Sacchi1, G. Selivanova2, S. Soddu1
1Dept Experimental Oncology, Regina Elena Cancer Inst. (Rome); 2Dept Microbiology, Tumor and Cell Biology, Karolinska Inst (Stockholm, Sweden)
PMS.9 · P35 
p53-independent mechanisms of HIPK2 induced sensitivity to antineoplastic drugs
C. Lazzari1, A. Prodosmo1, A. Costanzo2, A. Sacchi1, L. Guerrini3, S. Soddu1
1Dept Experimental Oncology, Regina Elena Cancer Inst (Roma); 2Dept Dermatology, Univ. Tor Vergata Rome (Rome); 3Dept Biomolecular and Biotechnological Sciences, Univ. Milan (MIlan)

p53-independent mechanisms of HIPK2 induced sensitivity to antineoplastic drugs
C. Lazzari1, A. Prodosmo1, A. Costanzo2, A. Sacchi1, L. Guerrini3, S. Soddu1
1Dept Experimental Oncology, Regina Elena Cancer Inst (Roma); 2Dept Dermatology, Univ. Tor Vergata Rome (Rome); 3Dept Biomolecular and Biotechnological Sciences, Univ. Milan (MIlan)
PMS.9 · P36 
PRDM1/BLIMP1 & PRDM2/RIZ in T CD4+ naïve lymphocytes activation
L. de Felice1, C. de Rosa1, M. Pacifico1, E. Di Zazzo1, N. Medici1, B. Moncharmont2, G. Matarese3, C. Abbondanza1
1Dip. Patologia generale, Seconda Univ. Napoli (Napoli); 2Dip. di Scienze per la Salute, Univ. degli Studi del Molise (Campobasso); 3Ist. di Endocrinologia e Oncologia Sperimentale, CNR (Napoli)

PRDM1/BLIMP1 & PRDM2/RIZ in T CD4+ naïve lymphocytes activation
L. de Felice1, C. de Rosa1, M. Pacifico1, E. Di Zazzo1, N. Medici1, B. Moncharmont2, G. Matarese3, C. Abbondanza1
1Dip. Patologia generale, Seconda Univ. Napoli (Napoli); 2Dip. di Scienze per la Salute, Univ. degli Studi del Molise (Campobasso); 3Ist. di Endocrinologia e Oncologia Sperimentale, CNR (Napoli)
PMS.9 · P38 
Study of the biological action of two tomato cysteine-rich peptides on human endothelial and carcinoma cells
C. Cavallini1, B. Molesini1, M. Vezzalini3, C. Sorio3, P. Delva4, P. Minuz4, T. Pandolfini2, A. Spena1
1Dept Scientific Technological, Univ. Verona (Verona); 2Dept DiSTeMeV, Univ. of Verona (Verona); 3Dept of Pathology, Univ. of Verona (Verona); 4Dept Biomedical and Surgical Sciences, Univ. of Verona (Verona)

Study of the biological action of two tomato cysteine-rich peptides on human endothelial and carcinoma cells
C. Cavallini1, B. Molesini1, M. Vezzalini3, C. Sorio3, P. Delva4, P. Minuz4, T. Pandolfini2, A. Spena1
1Dept Scientific Technological, Univ. Verona (Verona); 2Dept DiSTeMeV, Univ. of Verona (Verona); 3Dept of Pathology, Univ. of Verona (Verona); 4Dept Biomedical and Surgical Sciences, Univ. of Verona (Verona)
PMS.9 · P39 
Corylus avellana species as a new source of Taxol and taxanes to be used as antimitotic drug
L. Ottaggio1, F. Bestoso2, M. Sancandi2, M. Miele2,3
1National Inst. for Cancer Research (Genova); 2Laboratory of Plant and Pharmaceutical Biotechnology, Advanced Biotechnology Center (ABC) (Genova); 3Dept of Pharmaceutical Sciences, Univ. of Genova (Genova)

Corylus avellana species as a new source of Taxol and taxanes to be used as antimitotic drug
L. Ottaggio1, F. Bestoso2, M. Sancandi2, M. Miele2,3
1National Inst. for Cancer Research (Genova); 2Laboratory of Plant and Pharmaceutical Biotechnology, Advanced Biotechnology Center (ABC) (Genova); 3Dept of Pharmaceutical Sciences, Univ. of Genova (Genova)
PMS.9 · P40 
Diacylglycerol kinase is required for estrogen-induced proliferation, motility, and anoikis of endometrial cancer cells
I. Gregnanin1, P.E. Porporato2, B. Perego1, F. Chianale2, A. Romano1, A. Graziani2, N. Surico1, N. Filigheddu1
1Dept Clinical and Experimental Medicine, Univ Piemonte Orientale (Novara); 2Dept Medical Sciences, Univ Piemonte Orientale (Novara)

Diacylglycerol kinase is required for estrogen-induced proliferation, motility, and anoikis of endometrial cancer cells
I. Gregnanin1, P.E. Porporato2, B. Perego1, F. Chianale2, A. Romano1, A. Graziani2, N. Surico1, N. Filigheddu1
1Dept Clinical and Experimental Medicine, Univ Piemonte Orientale (Novara); 2Dept Medical Sciences, Univ Piemonte Orientale (Novara)
PMS.9 · P41 
Loss of Chp-1 (CHORD-containing protein 1) results in early embryonic lethality due to aneuploidy and mitotic defects
R. Ferretti1, V. Palumbo2, A. Di Savino1, S. Velasco1, S. Bonaccorsi2, M. Gatti2, G. Tarone1, M. Brancaccio1
1Dip. Genetica, Biologia e Biochimica, Univ. Torino (Turin); 2Insitute of Biology and Molecular Pathology CNR, and Dept of Genetics and Molecular Biology, Univ. of Rome “La Sapienza” (Rome)

Loss of Chp-1 (CHORD-containing protein 1) results in early embryonic lethality due to aneuploidy and mitotic defects
R. Ferretti1, V. Palumbo2, A. Di Savino1, S. Velasco1, S. Bonaccorsi2, M. Gatti2, G. Tarone1, M. Brancaccio1
1Dip. Genetica, Biologia e Biochimica, Univ. Torino (Turin); 2Insitute of Biology and Molecular Pathology CNR, and Dept of Genetics and Molecular Biology, Univ. of Rome “La Sapienza” (Rome)
view abstract
embargoed abstract